I see there are a handful of seats left for the webinar tomorrow. As members you have priority but if you want to attend please register soon. I thought you might like some information about our expert panel. As patients, we don't often get people at this level to participate in webinars.
Dr. Raymond Chungis Director of Hepatology and the Liver Center, Vice Chief of Gastroenterology and the Kevin and Polly Maroni Research Scholar at Massachusetts General Hospital. He has been an internationally recognized researcher in the areas of HCV virology and pathogenesis. He directs an NIH Cooperative Center for Human Immunology centered on HCV, and is co-PI of the Harvard HBV Consortium of the NIH HBV Research Network. He is contact PI of his Divisional T32 Training Grant, and holds several NIH R01 grants and an NIH K24 Mentorship Award.
He was recently Associate Editor of HEPATOLOGY and has previously served as a Councilor at Large for the AASLD. He has also served as co-Chair of the AASLD/IDSA HCV Guidance panel which is charged with issuing treatment recommendations for hepatitis C. He has authored more than 300 original articles, reviews, and editorials.
Dr. Vierling has also served as a co-investigator of FLF's Screening for Undiagnosed NAFLD NASH (SUNN-1) study.
Dr. John M. Vierling is Professor of Medicine and Surgery at the Baylor College of Medicine in Houston, Texas, where he also serves as Director of Baylor Liver Health and Chief of Hepatology. In addition, he is the Director of Advanced Liver Therapies, a center devoted to clinical research in hepatobiliary diseases at St. Luke's Episcopal Hospital. Dr. Vierling is board certified in internal medicine and gastroenterology and a Fellow of the American College of Physicians. He received his undergraduate degree in Biology at Stanford University with great distinction and departmental honors and was elected to Phi Beta Kappa. He obtained his M.D. degree from Stanford University School of Medicine, where he was elected to Alpha Omega Alpha.
